Aeglea BioTherapeutics Q3 EPS $(0.66) Down From $(0.54) YoY

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.66) per share. This is a 22.22 percent decrease over losses of $(0.54) per share from the same period last year.

Benzinga · 11/06/2019 13:54

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.66) per share. This is a 22.22 percent decrease over losses of $(0.54) per share from the same period last year.